Odrich Marc 🟢 acquired 98.2K shares (2 derivative) of LENZ Therapeutics, Inc. (LENZ) at $16.00 ($1.3M) Transaction Date: Jan 02, 2026 | Filing ID: 000002
Chevallard Daniel R. 🟢 acquired 98.2K shares (2 derivative) of LENZ Therapeutics, Inc. (LENZ) at $16.00 ($1.3M) Transaction Date: Jan 02, 2026 | Filing ID: 000002
Director Schimmelpennink Evert B. 🟢 acquired 358.1K shares (1 derivative) of LENZ Therapeutics, Inc. (LENZ) at $16.00 ($5.7M) Transaction Date: Jan 02, 2026 | Filing ID: 000002
Director Zoghbi Huda Y 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002
Director DeSilva Nishan M 🟢 acquired 10.4K shares (1 derivative) of Cartesian Therapeutics, Inc. (RNAC) at $6.76 Transaction Date: Jan 02, 2026 | Filing ID: 000039
Director Malik Kemal 🟢 acquired 10.4K shares (1 derivative) of Cartesian Therapeutics, Inc. (RNAC) at $6.76 Transaction Date: Jan 02, 2026 | Filing ID: 000037
Director ZENNER PATRICK J 🟢 acquired 10.4K shares (1 derivative) of Cartesian Therapeutics, Inc. (RNAC) at $6.76 Transaction Date: Jan 02, 2026 | Filing ID: 000035